Vasoactive intestinal polypeptide (VIP) is a neuropeptide present in the nerve fibers of normal lungs, where it acts to relax bronchial smooth muscle. To determine its presence or absence in the lungs of patients with asthma, we examined lung tissue obtained at autopsy or lobectomy from five patients with asthma and nine without asthma. The avidin-biotin-peroxidase complex technique was used to stain tissue for immunoreactivity to VIP. At least 80 tissue sections from each patient were examined microscopically; the airway diameter ranged from 100 microns to 1.2 cm. Immunoreactive VIP was seen within nerves in more than 92 percent of the sections from the lungs of patients without asthma. No VIP was seen in any of 468 sections we could evaluate that were obtained from the lungs of patients with asthma. As a control for the nonspecific destruction of neuropeptides, immunostaining for substance P was also carried out. Abundant amounts of this neuropeptide were seen within nerves in tissue from the lungs of all patients. We conclude that in patients with asthma there is a loss of VIP from the pulmonary nerve fibers that may diminish neurogenically mediated bronchodilation. Whether this loss is a cause or a result of asthma is unclear.
Source Information
Department of Medicine, University of Sydney, Australia.
This article has been cited by other articles:
Szema, A. M., Hamidi, S. A., Lyubsky, S., Dickman, K. G., Mathew, S., Abdel-Razek, T., Chen, J. J., Waschek, J. A., Said, S. I.
(2006). Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am. J. Physiol. Lung Cell. Mol. Physiol.
291: L880-L886
[Abstract][Full Text]
Canning, B. J.
(2006). Reflex regulation of airway smooth muscle tone. J. Appl. Physiol.
101: 971-985
[Abstract][Full Text]
Wu, Z.-X., Dey, R. D.
(2006). Nerve growth factor-enhanced airway responsiveness involves substance P in ferret intrinsic airway neurons. Am. J. Physiol. Lung Cell. Mol. Physiol.
291: L111-L118
[Abstract][Full Text]
Delgado, M., Pozo, D., Ganea, D.
(2004). The Significance of Vasoactive Intestinal Peptide in Immunomodulation. Pharmacol. Rev.
56: 249-290
[Abstract][Full Text]
Wu, Z.-X., Satterfield, B. E., Dey, R. D.
(2003). Substance P released from intrinsic airway neurons contributes to ozone-enhanced airway hyperresponsiveness in ferret trachea. J. Appl. Physiol.
95: 742-750
[Abstract][Full Text]
Beckett, P A, Howarth, P H
(2003). Pharmacotherapy and airway remodelling in asthma?. Thorax
58: 163-174
[Abstract][Full Text]
BARNES, P. J.
(2000). Endogenous Inhibitory Mechanisms in Asthma. Am. J. Respir. Crit. Care Med.
161: S176-181
[Full Text]
Busto, R., Carrero, I., Guijarro, L. G., Solano, R. M., Zapatero, J., Noguerales, F., Prieto, J. C.
(1999). Expression, pharmacological, and functional evidence for PACAP/VIP receptors in human lung. Am. J. Physiol. Lung Cell. Mol. Physiol.
277: L42-L48
[Abstract][Full Text]
CHANEZ, P., SPRINGALL, D., VIGNOLA, A. M., MORADOGHI-HATTVANI, A., POLAK, J. M., GODARD, P., BOUSQUET, J.
(1998). Bronchial Mucosal Immunoreactivity of Sensory Neuropeptides in Severe Airway Diseases. Am. J. Respir. Crit. Care Med.
158: 985-990
[Abstract][Full Text]
HALEY, K. J., SUNDAY, M. E., WIGGS, B. R., KOZAKEWICH, H. P., REILLY, J. J., MENTZER, S. J., SUGARBAKER, D. J., DOERSCHUK, C. M., DRAZEN, J. M.
(1998). Inflammatory Cell Distribution within and along Asthmatic Airways. Am. J. Respir. Crit. Care Med.
158: 565-572
[Abstract][Full Text]
Gololobov, G., Noda, Y., Sherman, S., Rubinstein, I., Baranowska-Kortylewicz, J., Paul, S.
(1998). Stabilization of Vasoactive Intestinal Peptide by Lipids. J. Pharmacol. Exp. Ther.
285: 753-758
[Abstract][Full Text]
Lucchini, R., Facchini, F, Turato, G, Saetta, M, Caramori, G, Ciaccia, A, Maestrelli, P, Springall, D., Polak, J., Fabbri, L, Mapp, C.
(1997). Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis. Am. J. Respir. Crit. Care Med.
156: 1963-1968
[Abstract][Full Text]
Bukantz, S. C., Lockey, R. F.
(1990). Allergy and Immunology. JAMA
263: 2623-2625
[Abstract]
Previous
